{"artifact":{"id":"open_question-53591b84-324d-4d20-b4a3-ded00ecdc313","artifact_type":"open_question","entity_ids":"[\"clinical\"]","title":"Which of latrepirdine's mechanisms contributes most to efficacy?","quality_score":0.5,"created_by":"backfill_open_questions","provenance_chain":"[]","content_hash":"faba3caee31ae93f47ea0c31b45b9e1e588475868530a2d6395fc78c6a9e47d5","metadata":{"status":"open","_origin":{"url":null,"type":"internal","tracked_at":"2026-04-26T03:27:53.045316"},"field_tag":"clinical","source_id":"clinical-trials-latrepirdine-dmb-1-phase-3","sub_field":"trials-latrepirdine-dmb-1-phase-3","source_kind":"wiki","question_hash":"98c0ed2c4ac087a8fdc0b53bbd5f7008278182a0cebcdbdb446fb2ef621206c1","question_text":"Which of latrepirdine's mechanisms contributes most to efficacy?","importance_elo":1500,"_schema_version":1,"evidence_summary":"Extracted from wiki page clinical-trials-latrepirdine-dmb-1-phase-3","tractability_score":0.5,"potential_impact_score":0.5},"created_at":"2026-04-25T20:27:53.045449-07:00","updated_at":"2026-04-25T20:27:53.045449-07:00","version_number":4,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-25T20:27:53.045449-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":null,"contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"775bcf24-ed78-46eb-9c06-3754908bfcfb","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"backfill_open_questions"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"wiki-clinical-trials-latrepirdine-dmb-1-phase-3","link_type":"derives_from","strength":0.9,"evidence":"{\"method\": \"open_question_wiki_crosslink\", \"cycle\": \"artifact-enrichment-2026-04-27\"}"}],"incoming_links":[],"current_artifact_id":"open_question-53591b84-324d-4d20-b4a3-ded00ecdc313","is_canonical":true,"supersede_chain":["open_question-53591b84-324d-4d20-b4a3-ded00ecdc313"]}